BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22526899)

  • 1. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
    Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
    Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
    Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
    Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic radical nephrectomy with hilar lymph node dissection in patients with advanced renal cell carcinoma.
    Simmons MN; Kaouk J; Gill IS; Fergany A
    Urology; 2007 Jul; 70(1):43-6. PubMed ID: 17656205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European temporal trends in the use of lymph node dissection in patients with renal cancer.
    Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T;
    Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates.
    Crispen PL; Breau RH; Allmer C; Lohse CM; Cheville JC; Leibovich BC; Blute ML
    Eur Urol; 2011 Jan; 59(1):18-23. PubMed ID: 20933322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell carcinoma].
    Shimazui T; Kawai K; Akaza H
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2073-5. PubMed ID: 15570943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software.
    Zhuang W; Chen J; Li Y; Liu W
    Int Urol Nephrol; 2020 Feb; 52(2):253-262. PubMed ID: 31612422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database.
    Joslyn SA; Sirintrapun SJ; Konety BR
    Urology; 2005 Apr; 65(4):675-80. PubMed ID: 15833507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
    Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
    BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lymph node dissection in renal cell carcinoma.
    Delacroix SE; Chapin BF; Wood CG
    Urol Clin North Am; 2011 Nov; 38(4):419-28, vi. PubMed ID: 22045173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
    Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis.
    Luo X; Li JX; Liu YT; Zou G; Yao WX; Qing GQ; Yang RL; Ye XY; Facchini G; Rossetti S
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6079-6090. PubMed ID: 31364109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.